China Pharma Holdings (CPHI) Return on Capital Employed (2011 - 2026)
China Pharma Holdings (CPHI) reported Return on Capital Employed of 3.75% for Q1 2026, up 714.0% on a YoY basis from 0.46% in Q1 2025, and up 24.67% quarter-over-quarter from 4.98% in Q4 2025.
China Pharma Holdings (CPHI) Return on Capital Employed (2011 - 2026) Analysis & Trends
China Pharma Holdings has reported Return on Capital Employed for 16 years, with the latest figure at 3.75% in Q1 2026.
- For the quarter ending Q1 2026, Return on Capital Employed rose 714.0% year-over-year to 3.75%; the trailing twelve-month figure through Mar 2026 stood at 3.75% (up 714.0% YoY), and the FY2025 full-year result was 5.13%, up 598.0% from the prior year.
- Return on Capital Employed for Q1 2026 stood at 3.75%, up from 4.98% in the prior quarter.
- The five-year high for Return on Capital Employed was 2.08% in Q3 2025, with the low at 68.32% in Q3 2022.
- Historically, Return on Capital Employed has averaged 15.36% across 5 years, with a median of 10.89% in 2025.
- Annual changes were most pronounced in 2022 — Return on Capital Employed tumbled 2985 bps — and 2023, when it soared 6642 bps.
- China Pharma Holdings' Return on Capital Employed stood at 22.89% in 2022, then jumped by 63 bps to 8.47% in 2023, then slumped by 53 bps to 12.93% in 2024, then soared by 61 bps to 4.98% in 2025, then advanced by 25 bps to 3.75% in 2026.
- The last three Return on Capital Employed figures came in at 3.75% (Q1 2026), 4.98% (Q4 2025), and 2.08% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 8.52% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 27.58% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 21.43% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 20.04% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 7.34% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 6.92% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -1.92% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 14.85% |
| 10 | China Pharma Holdings | 18.87 Mn | 18.70 Mn | 285,487.00 | -3.75% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.75% |
| Dec 31, 2025 | -4.98% |
| Sep 30, 2025 | 2.08% |
| Jun 30, 2025 | -3.29% |
| Mar 31, 2025 | -10.89% |
| Dec 31, 2024 | -12.93% |
| Sep 30, 2024 | -28.51% |
| Jun 30, 2024 | -21.15% |
| Mar 31, 2024 | -12.15% |
| Dec 31, 2023 | -8.47% |
| Sep 30, 2023 | -1.90% |
| Jun 30, 2023 | -2.28% |
| Mar 31, 2023 | -8.13% |
| Dec 31, 2022 | -22.89% |
| Sep 30, 2022 | -68.32% |
| Jun 30, 2022 | -27.90% |
| Mar 31, 2022 | -25.75% |
| Dec 31, 2021 | -28.88% |
| Sep 30, 2021 | -38.48% |
| Jun 30, 2021 | -45.49% |